InvestorsHub Logo
Followers 41
Posts 12419
Boards Moderated 0
Alias Born 11/18/2016

Re: mpreorder post# 33409

Tuesday, 09/12/2017 10:33:40 PM

Tuesday, September 12, 2017 10:33:40 PM

Post# of 108192
Mpre, I'm not sure where you saw that? The only mention of HER2 I can find in the PR is this: "As part of its portfolio refinement, the company has determined it will not pursue further clinical study of ADXS-HER2 at this time, but remains open to ISTs or licensing opportunities."

And they did not "kill" any ongoing trial. They simply "will not pursue further clinical study at this time."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News